Terms: = Lung cancer AND LDH AND Prognosis
184 results:
1. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.
Ying J; Huang Y; Ye X; Zhang Y; Yao Q; Wang J; Yang X; Yu C; Guo Y; Zhang X; Lv Q; Wang C; Mao W; Zhao A
Int Immunopharmacol; 2024 Jan; 126():111205. PubMed ID: 38029550
[TBL] [Abstract] [Full Text] [Related]
3. BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in lung Adenocarcinoma Cells.
Zhang Q; Chen X; Hu Y; Zhou T; Du M; Xu R; Chen Y; Tang P; Chen Z; Li J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834111
[TBL] [Abstract] [Full Text] [Related]
4. Association between weight loss and death in patients with malignant melanoma: A retrospective study of 28 cases.
Tanaka A; Miyazawa H; Yanagi T; Maeda T; Kitamura S; Ujiie H
J Dermatol; 2024 Mar; 51(3):463-466. PubMed ID: 37753543
[TBL] [Abstract] [Full Text] [Related]
5. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
6. [Correlation Analysis between Thyroid Function Abnormality and Efficacy in Patients
with Advanced Non-small Cell lung cancer after Immunotherapy].
Wang Y; Wang X; Cheng L; Zhang G
Zhongguo Fei Ai Za Zhi; 2023 May; 26(5):369-376. PubMed ID: 37316446
[TBL] [Abstract] [Full Text] [Related]
7. Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China.
Zhang C; Wu H; Xu G; Xu Y; Ma W; Li Z; Zhang J
BMC Cancer; 2023 Jun; 23(1):506. PubMed ID: 37271825
[TBL] [Abstract] [Full Text] [Related]
8. Influencing factors of efficacy and long-term use of amrubicin in patients with small cell lung cancer.
Takahara Y; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Sakuma T; Nishiki K; Nakase K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Mizuno S
Thorac Cancer; 2023 May; 14(14):1286-1293. PubMed ID: 36994539
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of serum α-HBDH levels in patients with lung cancer.
Yuan ZM; Wang LH; Chen C
World J Surg Oncol; 2023 Mar; 21(1):78. PubMed ID: 36872314
[TBL] [Abstract] [Full Text] [Related]
10. Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report.
Chen Z; Chen Z; Fan W; Zou Y; Zhang Y; Shi N; Jin H
World J Surg Oncol; 2023 Jan; 21(1):29. PubMed ID: 36721173
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors.
Olgun P; Diker O
Curr Med Res Opin; 2023 Mar; 39(3):425-431. PubMed ID: 36628474
[TBL] [Abstract] [Full Text] [Related]
12. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors.
Chen X; Li Z; Zhou J; Wei Q; Wang X; Jiang R
PeerJ; 2022; 10():e14566. PubMed ID: 36540802
[TBL] [Abstract] [Full Text] [Related]
13. [Predictive Value of LIPI and iSEND Immune Scoring System
in Immunotherapy of Advanced Non-small Cell lung cancer].
Luo Y; Wang X; Wang Y; Zhang G
Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):803-810. PubMed ID: 36419394
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors.
Zhao X; Wu X; Yu H; Wang H; Sun S; Hu Z; Liu C; Zhang J; Shao Y; Wang J
Front Immunol; 2022; 13():1003581. PubMed ID: 36341410
[TBL] [Abstract] [Full Text] [Related]
15. Investigation of poor predictive factors in extensive stage small cell lung cancer under etoposide-platinum-atezolizumab treatment.
Lim JU; Kang HS; Shin AY; Yeo CD; Kim SK; Kim JW; Kim SJ; Lee SH
Thorac Cancer; 2022 Dec; 13(23):3384-3392. PubMed ID: 36274214
[TBL] [Abstract] [Full Text] [Related]
16. [Effect of dNLR and LIPI scores on the prognosis of elderly patients with non-surgical treatment of non-small cell lung cancer].
Xie JH; Liu MM; Sun NN; Zhang L; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):975-980. PubMed ID: 36164700
[No Abstract] [Full Text] [Related]
17. Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers.
Comandatore A; Franczak M; Smolenski RT; Morelli L; Peters GJ; Giovannetti E
Semin Cancer Biol; 2022 Nov; 86(Pt 2):93-100. PubMed ID: 36096316
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors.
Rebuzzi SE; Prelaj A; Friedlaender A; Cortellini A; Addeo A; Genova C; Naqash AR; Auclin E; Mezquita L; Banna GL
Crit Rev Oncol Hematol; 2022 Nov; 179():103806. PubMed ID: 36087850
[TBL] [Abstract] [Full Text] [Related]
19. miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC.
Arora S; Singh P; Tabassum G; Dohare R; Syed MA
Free Radic Biol Med; 2022 Aug; 189():71-84. PubMed ID: 35853537
[TBL] [Abstract] [Full Text] [Related]
20. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
[TBL] [Abstract] [Full Text] [Related]
[Next]
